Trials / Unknown
UnknownNCT06242730
Doxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims at assessing effectiveness of offering event-driven Doxy PEP and 4CMenB immunization in MSM/TGW at high STI risk. It plans to offer this STI prevention package to all MSM/TGW in the SHCS who are at risk of STI and then comparing 12-months STI incidence between those accepting and those not accepting the prevention package. The proposal further hosts two interesting sub-studies: One assessing potential effect of Doxy PEP on the microbiome and the other one assessing potential impact of Doxy PEP on TP, MG and CT resistance.
Conditions
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-10-31
- Completion
- 2025-10-31
- First posted
- 2024-02-05
- Last updated
- 2024-02-05
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06242730. Inclusion in this directory is not an endorsement.